Literature DB >> 22886123

Relationship between the occurrence of symptoms of anxiety and depression, quality of life, and level of acceptance of illness in patients with type 2 diabetes.

Jolanta Lewko1, Wiesław Zarzycki, Elżbieta Krajewska-Kułak.   

Abstract

OBJECTIVES: To determine the occurrence of symptoms of anxiety and depression in patients with type 2 diabetes, as well as to assess the relationship between the occurrence of symptoms of anxiety and depression, quality of life, and level of acceptance of illness of patients in northeastern Poland.
METHODS: A cross-sectional study was conducted on 126 patients with type 2 diabetes in the Department of Endocrinology, Diabetes and Internal Diseases, Medical University of Bialystok, Bialystok, Poland from February 2010 to March 2011. Three questionnaires were administered: Hospital Anxiety and Depression Scale, Acceptance of Illness Scale, and SF-36v2 Scale.
RESULTS: Symptoms of anxiety were found in 30.4% of patients and depression in 32%, more often in women than men (20.6% versus 10.3% for anxiety and 22.2% versus 10.3% for depression). Multiple regression analysis revealed that 50% of variance on the illness acceptance scale affected the quality of life in relation to the general health PCS and MCS.
CONCLUSION: Symptoms of anxiety and depression adversely affect the degree of acceptance of illness and significantly lower the quality of life in patients with diabetes. Lowered quality of life is an important predictor of worse acceptance of illness by patients.

Entities:  

Mesh:

Year:  2012        PMID: 22886123

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  7 in total

1.  Metformin produces anxiolytic-like effects in rats by facilitating GABAA receptor trafficking to membrane.

Authors:  Jun Fan; Di Li; Hong-Sheng Chen; Jian-Geng Huang; Jun-Feng Xu; Wen-Wen Zhu; Jian-Guo Chen; Fang Wang
Journal:  Br J Pharmacol       Date:  2018-11-29       Impact factor: 8.739

2.  The acceptance of illness, the intensity of pain and the quality of life in patients with lung cancer.

Authors:  Mariusz Chabowski; Jacek Polański; Beata Jankowska-Polanska; Katarzyna Lomper; Dariusz Janczak; Joanna Rosinczuk
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

3.  The Effect of Religious Coping on Disease Acceptance and Management Among Patients with Diabetes in Turkey.

Authors:  Selda Celik; Feride Taskin Yilmaz; Gulden Anataca
Journal:  J Relig Health       Date:  2021-04-27

4.  Negative Affectivity Predicts Lower Quality of Life and Metabolic Control in Type 2 Diabetes Patients: A Structural Equation Modeling Approach.

Authors:  Chiara Conti; Giulia Di Francesco; Lara Fontanella; Danilo Carrozzino; Chiara Patierno; Ester Vitacolonna; Mario Fulcheri
Journal:  Front Psychol       Date:  2017-05-24

5.  Mental health issues decrease diabetes-specific quality of life independent of glycaemic control and complications: findings from Australia's living with diabetes cohort study.

Authors:  Maria Donald; Jo Dower; Joseph R Coll; Peter Baker; Bryan Mukandi; Suhail A R Doi
Journal:  Health Qual Life Outcomes       Date:  2013-10-16       Impact factor: 3.186

6.  Factors Affecting the Quality of Life and the Illness Acceptance of Pregnant Women with Diabetes.

Authors:  Agnieszka Bień; Ewa Rzońca; Angelika Kańczugowska; Grażyna Iwanowicz-Palus
Journal:  Int J Environ Res Public Health       Date:  2015-12-22       Impact factor: 3.390

7.  Health and quality of life outcomes impairment of quality of life in type 2 diabetes mellitus: a cross-sectional study.

Authors:  Jessie N Zurita-Cruz; Leticia Manuel-Apolinar; María Luisa Arellano-Flores; Alejandro Gutierrez-Gonzalez; Alma Gloria Najera-Ahumada; Nelly Cisneros-González
Journal:  Health Qual Life Outcomes       Date:  2018-05-15       Impact factor: 3.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.